Aldeyra Therapeutics (ALDX)

Aldeyra Therapeutics (ALDX) Financial Statements


Aldeyra Therapeutics Financial Overview

Aldeyra Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.508; its P/E ratio is -7.52; Aldeyra Therapeutics is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.11. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -7.58M$ -4.24M$ -7.65M$ -8.46M$ -15.12M
EBITDA$ -7.52M$ -4.17M$ -7.49M$ -8.30M$ -14.98M
Net Income Common Stockholders$ -8.08M$ -4.75M$ -8.19M$ -8.99M$ -15.62M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 80.55M$ 0.00$ 0.00$ 0.00$ 0.00
Total Assets$ 141.35M$ 148.33M$ 147.28M$ 155.62M$ 168.21M
Total Debt$ 15.66M$ 15.66M$ 16.18M$ 16.15M$ 16.11M
Net Debt$ -64.89M$ 15.66M$ 16.18M$ 16.15M$ 16.11M
Total Liabilities$ 27.88M$ 28.53M$ 24.27M$ 25.73M$ 30.98M
Stockholders Equity$ 113.42M$ 119.80M$ 123.01M$ 129.88M$ 137.24M
Cash Flow-
Free Cash Flow$ -9.97M$ 500.44K$ -8.02M$ -13.36M$ -9.44M
Operating Cash Flow$ -9.97M$ 500.44K$ -8.02M$ -13.36M$ -9.44M
Investing Cash Flow$ -30.38M---$ 30.00M
Financing Cash Flow$ 18.19K$ -1.01M$ -315.76K$ 5.29K$ 52.56K
Currency in USD

Aldeyra Therapeutics Earnings and Revenue History

Aldeyra Therapeutics Debt to Assets

Aldeyra Therapeutics Cash Flow

Aldeyra Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis